Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukemia) refractory (DBCOND0089326)

Identifiers

Synonyms

Lymphoblastic Lymphoma, Refractory / Refractory Lymphoblastic Lymphoma / Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukaemia) refractory / Precursor T-lymphoblastic lymphoma/leukaemia refractory / Precursor T-lymphoblastic lymphoma/leukemia refractory

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05292664	Venetoclax Basket Trial for High Risk Hematologic Malignancies	Asparaginase Erwinia chrysanthemi Azacitidine Calaspargase pegol Calcium Cortisone Cytarabine Dexamethasone Dexrazoxane Doxorubicin Hydrocortisone Hydrocortisone phosphate Hydrocortisone succinate Leucovorin Methotrexate Venetoclax Vincristine	treatment	1	recruiting
NCT05032183	Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	Coenzyme M Cortisone Cyclophosphamide Cytarabine Dexamethasone Filgrastim Leucovorin Mercaptopurine Methopterin Methotrexate Methoxamine Muplestim Pegfilgrastim Prednisone Rituximab Tagraxofusp Vincristine	treatment	1 / 2	active_not_recruiting
NCT03136146	Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia	Beta-D-Glucose Bortezomib Bortezomib D-mannitol Clofarabine Cyclophosphamide Dexamethasone Etoposide Filgrastim Ofatumumab Pegfilgrastim Rituximab Vincristine	treatment	2	recruiting
NCT01658007	Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma	Sirolimus	treatment	0	terminated